![](/img/cover-not-exists.png)
A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma
Ciuleanu, T., Bazin, I., Lungulescu, D., Miron, L., Bondarenko, I., Deptala, A., Rodriguez-Torres, M., Giantonio, B., Fox, N. L., Wissel, P., Egger, J., Ding, M., Kalyani, R. N., Humphreys, R., GribbiLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw004
Date:
January, 2016
File:
PDF, 710 KB
english, 2016